EUVIMEDEUVIMED entdecken
ZwillingsstudieOpen Access · CC BY 4.0

Differential Neuronal Development in iPSC ‐Derived Neural Stem Cells From Monozygotic Twin Cases With Treatment‐Resistant Schizophrenia and Discordant Responses to Clozapine

Shotaro Kawano, Sayaka Katayama, Masaya Ogawa, Rei Endo, Naoto Ikeda, Yuuri Ikeuchi, Tomoki Mita, Hikari Takei, Nanaka Gotoda-Nishimura, Daiki Miura, Hotaka Fukushima, Hitoshi Hashimoto und 2 weitere

Neuropsychopharmacology Reports · 2026-06 · 46 (2)

DOI: 10.1002/npr2.70097 ↗

Kurz gefasst

Zwillingsstudie in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 22.03.2026. Verfasst von Shotaro Kawano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan. Hauptthemen laut MEDLINE: Antipsychotic Agents, Clozapine, Induced Pluripotent Stem Cells, Neural Stem Cells. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment‐resistant schizophrenia (TRS) affects 20%–30% of individuals diagnosed with schizophrenia and is effectively managed with clozapine. However, the molecular and cellular mechanisms that underlie its efficacy remain largely unclear. We previously generated induced pluripotent stem cell (iPSC) lines from a unique pair of monozygotic twins with TRS. One twin responded to clozapine (CLZ‐res), while the other did not (CLZ‐non‐res). Building on our previous study of these twins, we included healthy controls and focused on the early developmental stages of neuronal differentiation. To investigate the phenotypic differences in the developmental stages of neural cells between patient‐derived cells, we differentiated each iPSC line—from both patients and healthy individuals—into neural stem cells (NSCs) and subsequently induced the differentiation of NSCs into neurons. Our results demonstrated that NSCs derived from patients' iPSC lines exhibited impaired neuronal differentiation, with a more pronounced reduction in differentiation observed in CLZ‐non‐res cells than in CLZ‐res cells. RNA sequencing analysis revealed significant differences in the expression of genes involved in neuronal development between CLZ‐res and CLZ‐non‐res cells. These findings suggest that the differences in neuronal development may contribute to the variability in clozapine responsiveness. Although this study is limited to a single twin pair, this unique human model provides valuable insights into the molecular and cellular mechanisms underlying differential clozapine responses, offering a promising framework for the development of effective treatments for patients with TRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsClozapineInduced Pluripotent Stem CellsNeural Stem CellsNeurogenesisSchizophrenia, Treatment-ResistantAdultFemaleHumansMaleCell DifferentiationNeuronsTwins, Monozygotic

Stichwörter der Autor:innen

clozapineiPSCmonozygotic twinsneural developmentneuronal differentiationtreatment‐resistant schizophrenia

Substanzen

Antipsychotic AgentsClozapine

Autor:innen und Institutionen

  • Laboratory of Molecular Biology, Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan.
  • Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan.
  • Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University o…
  • D3 Center, Osaka University, Suita, Japan.
  • Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Japan.
  • Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Suita, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation

Zitieren

APA

Kawano, S., Katayama, S., Ogawa, M., Endo, R., Ikeda, N., Ikeuchi, Y., Mita, T., Takei, H., Gotoda-Nishimura, N., Miura, D., Fukushima, H., Hashimoto, H., Hashimoto, R., & Nakazawa, T. (2026). Differential Neuronal Development in iPSC ‐Derived Neural Stem Cells From Monozygotic Twin Cases With Treatment‐Resistant Schizophrenia and Discordant Responses to Clozapine. Neuropsychopharmacology Reports, 46(2). https://doi.org/10.1002/npr2.70097

Vancouver

Kawano S, Katayama S, Ogawa M, Endo R, Ikeda N, Ikeuchi Y, et al. Differential Neuronal Development in iPSC ‐Derived Neural Stem Cells From Monozygotic Twin Cases With Treatment‐Resistant Schizophrenia and Discordant Responses to Clozapine. Neuropsychopharmacology Reports. 2026;46(2). doi:10.1002/npr2.70097

BibTeX
@article{Kawano2026,
  author = {Kawano, Shotaro and Katayama, Sayaka and Ogawa, Masaya and Endo, Rei and Ikeda, Naoto and Ikeuchi, Yuuri and Mita, Tomoki and Takei, Hikari and Gotoda-Nishimura, Nanaka and Miura, Daiki and Fukushima, Hotaka and Hashimoto, Hitoshi and Hashimoto, Ryota and Nakazawa, Takanobu},
  title = {Differential Neuronal Development in iPSC ‐Derived Neural Stem Cells From Monozygotic Twin Cases With Treatment‐Resistant Schizophrenia and Discordant Responses to Clozapine},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  volume = {46},
  number = {2},
  doi = {10.1002/npr2.70097}
}
Kostenlos starten →